HE

HuaKong Equity Investment

Asia, Beijing, China, Beijing

Description

HuaKong Equity Investment

Investor Profile

HuaKong Equity Investment has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Medical Device.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical Device
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HuaKong Equity Investment frequently co-invest with?

Guangzhou Yuexiu Industrial Investment Fund
Asia, Guangdong, China, Guangzhou
Co-Investments: 1
QS
North America, Colorado, United States, Denver
Co-Investments: 1
Sangel Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by HuaKong Equity Investment?

Sirnaomics

Gaithersburg, Maryland, United States

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.

BiopharmaBiotechnologyMedical DevicePharmaceutical
Series CJun 6, 2018
Amount Raised: $25,000,000